Annual report pursuant to Section 13 and 15(d)

Note Payable - Additional Information (Detail)

v3.8.0.1
Note Payable - Additional Information (Detail)
9 Months Ended 12 Months Ended
Jun. 05, 2017
USD ($)
May 20, 2016
USD ($)
Apr. 22, 2016
USD ($)
Jun. 30, 2015
USD ($)
Installments
Mar. 31, 2016
USD ($)
Nov. 30, 2017
USD ($)
Nov. 30, 2016
USD ($)
Aug. 26, 2016
USD ($)
Jul. 01, 2016
USD ($)
Debt Instrument [Line Items]                  
Note payable           $ 5,295,183 $ 7,819,750    
Debt instrument payment           2,650,000 1,509,107    
Notes payable, principal amount outstanding           7,500,100 10,150,100    
Gain on extinguishment of debt             300,593    
Interest expense on notes payable           446,439 229,314    
Interest expense           1,302,650 947,340    
Debt issuance costs           378,785      
Amortization of debt issuance costs           125,434 48,435    
Texas Capital Bank National Association [Member] | Amended And Restated Promissory Notes [Member]                  
Debt Instrument [Line Items]                  
Principal paid           2,633,000 633,000    
Interest expense           $ 406,139 164,799    
TCB and CrowdOut Capital LLC [Member]                  
Debt Instrument [Line Items]                  
Subordinated loan   $ 650,000              
Repayment of subordinated debt $ 650,000                
TCB and CrowdOut Capital LLC [Member] | Subordinated Debt [Member]                  
Debt Instrument [Line Items]                  
Line of credit facility, interest rate   12.00%              
Line of credit facility, expiration date   Jul. 31, 2021              
Line of credit facility, description           Per a promissory note dated May 20, 2016 between the Company and CrowdOut, interest at 12% per annum on the principal sum of $650,000 is payable monthly with a maturity date of July 2021, at which time, the principal amount of $650,000 was payable.      
Line of credit facility, frequency of payment           Monthly      
Interest expense           $ 40,300 42,250    
Interest paid $ 867                
Notes Payable [Member]                  
Debt Instrument [Line Items]                  
Asset purchase agreement commencement date       Jul. 31, 2015          
Asset purchase agreement closing date       Jun. 30, 2019          
Interest expense on notes payable           $ 0 $ 22,265    
Senior Credit Facilities [Member] | Texas Capital Bank National Association [Member] | Term Loan [Member]                  
Debt Instrument [Line Items]                  
Line of credit facility, description           Subject to the terms of the Agreement, on May 20, 2016, TCB advanced the Company $100.00. On July 1, 2016, TCB advanced the remaining principal amount of $7,999,900 per a promissory note dated May 20, 2016 between the Company and TCB, at a rate of 3.75% per annum plus LIBOR, payable monthly with a maturity date of July 2021.      
Line of credit facility, frequency of payment           Monthly      
Line of credit facility, interest rate description           3.75% per annum plus LIBOR      
Senior Credit Facilities [Member] | Texas Capital Bank National Association [Member] | Promissory Notes [Member] | Term Loan [Member]                  
Debt Instrument [Line Items]                  
Line of credit facility, amount advanced                 $ 7,999,900
Senior Credit Facilities [Member] | London Interbank Offered Rate (LIBOR) [Member] | Texas Capital Bank National Association [Member] | Term Loan [Member]                  
Debt Instrument [Line Items]                  
Term loan, maximum borrowing capacity   $ 8,000,000              
Line of credit facility, amount advanced   $ 100.00              
Line of credit facility, interest rate   3.75%              
Line of credit facility, expiration date   Jul. 31, 2021              
Amended Senior Credit Facility [Member] | Texas Capital Bank National Association [Member] | Amended And Restated Promissory Notes [Member] | Term Loan [Member]                  
Debt Instrument [Line Items]                  
Line of credit facility, amount advanced               $ 2,133,433  
Asset Purchase Agreement [Member]                  
Debt Instrument [Line Items]                  
Note payable       $ 1,300,000          
Notes payable, principal amount outstanding           $ 1,300,000      
Asset Purchase Agreement [Member] | CytoMedical [Member]                  
Debt Instrument [Line Items]                  
Debt instrument payment     $ 778,287   $ 269,443        
Asset Purchase Agreement [Member] | Notes Payable [Member]                  
Debt Instrument [Line Items]                  
Number of monthly installments | Installments       48          
Repayment interval           Monthly      
Monthly installment amount       $ 29,938          
Annual interest rate       5.00%